Independent thinkers. Helpful. High moral character. Experienced entrepreneurs know how valuable and how rare these things are, and Dolby Family Ventures exemplifies them.
Abe Heifets
Co-Founder and former CEO
Atomwise
Dolby Family Ventures was critical to our early success at Cytovale. The team's unique insights at the intersection of life sciences and technology, along with seasoned guidance on navigating a young company's challenges, propelled us forward far more than the capital alone.
Ajay Shah
Co-Founder and CEO
Cytovale
DFV is distinguished by its strategic focus on supporting early-stage companies with innovative technologies in the biotech and pharmaceutical sectors. DFV's emphasis on fostering groundbreaking research and development, combined with its commitment to long-term partnerships, helps companies like Cerevance bring forward novel medicines for challenging diseases.
Craig Thompson
CEO
Cerevance
Sourav, Dave, and the Dolby Family Ventures team have been a genuine partner with all parts of venture creation and development. One of the things I think sets DFV apart in the ecosystem is their unique ability to combine scientific knowledge with strategic insights and connections. Sourav's relationships with neurology experts and CNS-educated investors, and his willingness to proactively make connections, have been particularly helpful. The value that DFV, Sourav, and Dave provide to Monument and other companies in the field is exceptional. We are very glad to have them as partners in dedication to our mission.
Derek A. Small
Co-founder & CEO
Monument Biosciences
DFV is very well plugged in to the neurotech and therapeutics ecosystems. The team is super sharp, kind, and supportive. Their collaborative approach to company building is a great match for founder CEOs looking to build something with positive societal impact.
Jacob Robinson
CEO
Motif Neurotech
Dolby Family Ventures have been a lasting partner from Series A through D. In matters of governance, fundraising, and business operations they care to take time to understand our needs and provide valuable insight.
Joe Laurienti
Founder and former CEO
Ursa Major Technologies
I appreciate the genuine commitment of the DFV team to overcoming Alzheimer’s Disease, and believe that their multipronged approach to AD effectively matches the complexity of this disorder.
Lennart Mucke
Director and Joseph B. Martin Distinguished Professor of Neuroscience
Gladstone Institute of Neurological Disease & UCSF
DFV is more than just an investor – they are a strategic partner and helpful teammate in our efforts to disrupt markets and blaze new scientific trails. Following extensive due diligence, Sourav and the team bring vision, operational experience, and a broad network to support the company’s success. I’d recommend DFV to any neuroscience-focused founder who’s looking to make a difference, and beyond just capital, needs sophisticated, experienced, connected teammates to make that vision a reality.
Mark Rus
CEO
Delix Therapeutics
Alzheimer’s will ultimately be conquered by broad collaboration. The Dolby Family Ventures fund is uniquely focused on enabling small companies who are developing diagnostic and therapeutic products for AD. Their laser focus and expertise has led to considerable success.
Michael Weiner
MD, Emeritus Professor in Residence in Radiology and Biomedical Imaging, Medicine, Psychiatry, and Neurology and Founder
UCSF & Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Dolby Family Ventures played an instrumental role early in our journey building momentum by bringing in co-investors. Since then, the team has provided high-level customer introductions and quality introductions to follow-on investors. Their reputation as a high-quality technical investor is well earned.
Nicholas Flanders
Co-Founder and CEO
Twelve
The DFV team were great mentors with a values driven mission and a steady hand. You made yourselves available in all the right ways, giving the company guidance but also letting the team figure out their own culture and direction.
Todd Huffman
Co-founder and former CEO
3Scan/Strateos
